Ledger.Open graph →
SEC Form D · filed January 26, 2015

CoLucid Pharmaceuticals, Inc

Offering
$37.1M
Sold
$37.1M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
DURHAM, NC
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Jesse I. Treu · Princeton, NJDirectorTimothy C. Gupton · Raleigh, NCExecRichard J. Markham · Princeton, NJDirectorArthur M. Pappas · Durham, NCExec · DirectorLuc C. Marengere · Westmount, Quebec, CanadaDirectorBrian D. Finn · Marysville, OHExecAdam D. Hanft · Marysville, OHDirectorStephen L. Johnson · Marysville, OHDirectorBernice C. Kuca · Durham, NCExecMathers P. Thomas · Durham, NCExec · DirectorNadia C. Rupniak · Durham, NCExecMartin C. Edwards · Hellerup, NetherlandsDirectorJames Hagedorn · Marysville, OHExec · DirectorJohn R. Vines · Marysville, OHExecThomas N. Kelly Jr · Marysville, OHDirectorIvan C. Smith · Marysville, OHExec · DirectorBernice C. Kuca · Durham, NCExecMathers P. Thomas · Durham, NCExec · DirectorNadia C. Rupniak · Durham, NCExecMartin C. Edwards · Hellerup, NetherlandsDirectorLuc C. Marengere · Westmount, Quebec, CanadaDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗